Cargando…
A Case of Non-Small Cell Lung Cancer with Possible “Disease Flare” on Nivolumab Treatment
Background. Recent clinical trials proven the clinically significant efficacy and tolerability of nivolumab, a programmed death 1 (PD-1) inhibitor, in previously treated patients with non-small cell lung cancer (NSCLC). Case Presentation. Here, we describe the case of a patient who experienced possi...
Autores principales: | Chubachi, Shotaro, Yasuda, Hiroyuki, Irie, Hidehiro, Fukunaga, Koichi, Naoki, Katsuhiko, Soejima, Kenzo, Betsuyaku, Tomoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223009/ https://www.ncbi.nlm.nih.gov/pubmed/28116195 http://dx.doi.org/10.1155/2016/1075641 |
Ejemplares similares
-
Secondary Brain Neoplasm after Stereotactic Radiosurgery in Patients with Metastatic Non-small Cell Lung Cancer
por: Nukaga, Shigenari, et al.
Publicado: (2018) -
EGFR-mutant Non-small Cell Lung Cancer Accompanied by Transient Asymptomatic Pulmonary Opacities Successfully Treated with “Stop-And-Go” Osimertinib
por: Kobayashi, Keigo, et al.
Publicado: (2017) -
Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease
por: Chubachi, Shotaro, et al.
Publicado: (2017) -
Successful Steroid Treatment of Pembrolizumab-induced Agranulocytosis That Developed after Splenectomy in a Patient with Non-small-cell Lung Cancer
por: Okuzumi, Shinichi, et al.
Publicado: (2022) -
Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer
por: Kobayashi, Keigo, et al.
Publicado: (2018)